Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Amphastar Pharmaceuticals, Inc. Director's Dealing 2016

Mar 30, 2016

10216_dirs_2016-03-29_ae064dd2-05db-4c72-b0ec-604b5b0618b2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Amphastar Pharmaceuticals, Inc. (AMPH)
CIK: 0001297184
Period of Report: 2016-03-26

Reporting Person: Zhou Rong (EVP, Production)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-03-26 Common Stock F 568 $11.96 Disposed 37137 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 99668 Indirect
Common Stock 5000 Indirect

Footnotes

F1: The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of deferred stock units, or DSUs.

F2: The shares are held of record by the Zhou Family Trust for which the reporting person serves as a trustee.

F3: The shares are held of record by the reporting person's spouse.